Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil.

Objective: The Erasmus Guillain Barre Outcome Score (EGOS) is a prognostic model that predicts the chance of being able to walk independently at 6 months after Guillain Barré syndrome (GBS). This study was conducted aiming to determine the validity of EGOS in a Brazilian population.

Material And Methods: Data collected from GBS patients in Rio Grande do Norte, Brazil, were used to determine the validity of EGOS.